Event report: C5 Pharma & Biotech Patent Litigation in Europe (Day 1), Plausibility, UPC and antibody IP strategy By Dr Rose Hughes on Tuesday, May 27, 2025 antibody inventions epo event report G 1/24 G 2/21 patents PatKat pharma patents plausibility Rose Hughes upc +
Irish Supreme Court in Merck v Clonmel puts "adequacy of damages" back in the balance when granting preliminary junctions By Annsley Merelle Ward on Wednesday, August 14, 2019 American Cyanamid AmeriKat balance of convenience clearing the way damages as an adequate remedy Ireland Merck pharma patents preliminary injunction SPCs +
Fordham 27 (Report 1): Key Current IP Issues: Reflections & Analysis By Annsley Merelle Ward on Thursday, April 25, 2019 #IPKat AI AmeriKat Artificial Intelligence event report exhaustion fordham 2019 incentives injunctive relief IP value licensing open source pharma patents US legislation website blocking +